Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

GU Cancers 2019 | Genomic insights and biomarkers for treatment selection in bladder cancer

Yair Lotan • 15 Feb 2019
GU Cancers 2019
Bladder Cancer Genitourinary Cancer

Yair Lotan, MD, of the University of Texas Southwestern Medical Center, Dallas, TX, discusses how identifying clinical biomarkers can significantly help in the selection of treatments for bladder cancer patients. This video was taken at the 2019 Genitourinary Cancers Symposium, held in San Francisco, CA.

More from Yair Lotan

3:32
DNA damage repair mutations and poor chemotherapy response in bladder cancer
Yair Lotan • 14 Feb 2019

Related Videos

2:26
Prognostic factors of renal cell cancer in elderly patients
Teemu Murtola • 9 Apr 2024
2:44
The effect of hypoxia on lipid metabolism and prostate cancer tumor growth
Teemu Murtola • 9 Apr 2024
3:07
Serum thymidine kinase 1 as a predicative biomarker in prostate cancer
Teemu Murtola • 9 Apr 2024
0:57
Real-world outcomes of 177Lu-PSMA-617 in mCRPC
Hannah McManus • 8 Apr 2024
The content of VJOncology is intended for healthcare professionals